acetylcysteine has been researched along with Pneumonia, Viral in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 10 (83.33) | 2.80 |
| Authors | Studies |
|---|---|
| Baratashvili, N; Gvaramia, L; Kandelaki, M; Samsonia, M | 1 |
| Andreou, A; Filippou, D; Sipsas, N; Trantza, S; Tsiodras, S | 1 |
| Corn, J; Poe, FL | 1 |
| Wu, J | 1 |
| Jorge-Aarón, RM; Rosa-Ester, MP | 1 |
| Goldenberg, R; Ibrahim, H; Kon, Z; Lewis, T; Perl, A; Smith, D; Staniloae, C; Williams, M; Yarta, K | 1 |
| Becker, C; Benoliel, JJ; Elbim, C; Frère, C; Hémadi, M; Laforge, M; Massaad, C; Nuss, P | 1 |
| Raftery, MJ; Samstag, Y; Schönrich, G | 1 |
| Alamdari, AH; Alamdari, DH; Amini, S; Banpour, H; Damsaz, M; Keramati, MR; Koliakos, G; Moghaddam, AB; Yarahmadi, A; Zarmehri, AM | 1 |
| Chen, B; Leung, EL; Liu, Y; Luo, G; Qian, X; Tang, Y; Wang, M; Wu, C; Zhang, Y | 1 |
| Legnani, D | 1 |
| Cheng, F; Lai, KY; Ng, WY; Osburga Chan, PK; Wong, KF | 1 |
4 review(s) available for acetylcysteine and Pneumonia, Viral
| Article | Year |
|---|---|
COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2.
Topics: Acetylcysteine; Adenosine Monophosphate; Adjuvants, Immunologic; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Autophagy; Betacoronavirus; Colchicine; Copper; Coronavirus Infections; COVID-19; Cytidine; Drug Synergism; Drug Therapy, Combination; Humans; Hydroxylamines; Inflammation; Nitric Oxide; Pandemics; Pneumonia, Viral; Prodrugs; Ribonucleosides; SARS-CoV-2; Virus Internalization; Virus Replication | 2020 |
Tackle the free radicals damage in COVID-19.
Topics: Acetylcysteine; Animals; Antioxidants; Ascorbic Acid; Azithromycin; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Drug Therapy, Combination; Free Radicals; Glutathione; Humans; Hydroxychloroquine; Mice; Multiple Organ Failure; NF-E2-Related Factor 2; Nitric Oxide; Orthomyxoviridae Infections; Oxidative Stress; Pandemics; Pneumonia, Viral; Reactive Oxygen Species; SARS-CoV-2; Severe Acute Respiratory Syndrome | 2020 |
Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression.
Topics: Acetylcysteine; Antioxidants; Ascorbic Acid; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokines; Extracellular Traps; Host-Pathogen Interactions; Humans; Immunity, Innate; Lymphopenia; Neutrophils; NF-kappa B; Oxidative Stress; Pandemics; Pneumonia, Viral; Reactive Oxygen Species; SARS-CoV-2; T-Lymphocytes | 2020 |
[Acute bacterial exacerbation of chronic obstructive pulmonary disease and biofilm].
Topics: Acetylcysteine; Anti-Infective Agents; Antioxidants; Biofilms; Bronchi; Bronchitis; Cystic Fibrosis; Humans; Lung; Pneumocystis carinii; Pneumonia, Bacterial; Pneumonia, Pneumocystis; Pneumonia, Viral; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive | 2009 |
8 other study(ies) available for acetylcysteine and Pneumonia, Viral
| Article | Year |
|---|---|
NEUROPROTECTIVE AND ANTIOXIDANT POTENTIAL OF MONTELUKAST-ACETYLCYSTEINE COMBINATION THERAPY FOR BRAIN PROTECTION IN PATIENTS WITH COVID-19 INDUCED PNEUMONIA.
Topics: Acetylcysteine; Adult; Aged; Antioxidants; COVID-19; Diabetes Mellitus, Type 2; Humans; Interleukin-6; Microcirculation; Middle Aged; Oxygen; Pneumonia, Viral; Respiratory Distress Syndrome; SARS-CoV-2 | 2023 |
N-Acetylcysteine: A potential therapeutic agent for SARS-CoV-2.
Topics: Acetylcysteine; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Free Radicals; Glutathione; Humans; Inflammation; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidation-Reduction; Oxidative Stress; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severe Acute Respiratory Syndrome; T-Lymphocytes; Tumor Necrosis Factor-alpha; Viral Load | 2020 |
N-acetylcysteine as a potential treatment for COVID-19.
Topics: Acetylcysteine; Angiotensin II; Antioxidants; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokines; Humans; Oxidative Stress; Pandemics; Pneumonia, Viral; SARS-CoV-2; Virus Internalization | 2020 |
Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine.
Topics: Acetylcysteine; Adult; Antioxidants; Antirheumatic Agents; Betacoronavirus; Biomarkers; C-Reactive Protein; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Drug Administration Schedule; Ferritins; Fibrin Fibrinogen Degradation Products; Glucosephosphate Dehydrogenase Deficiency; Humans; Hydroxychloroquine; Inflammation; Male; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome | 2020 |
Tissue damage from neutrophil-induced oxidative stress in COVID-19.
Topics: Acetylcysteine; Antioxidants; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokines; Drug Therapy, Combination; Extracellular Traps; Gene Expression Regulation; Glycine; Host-Pathogen Interactions; Humans; Immunity, Innate; Lung; Lymphocytes; Neutrophils; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Pandemics; Pneumonia, Viral; Proteinase Inhibitory Proteins, Secretory; Reactive Oxygen Species; SARS-CoV-2; Severity of Illness Index; Sulfonamides; Superoxide Dismutase | 2020 |
Application of methylene blue -vitamin C -N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial.
Topics: Acetylcysteine; Ascorbic Acid; Clinical Trials, Phase I as Topic; Compassionate Use Trials; Coronavirus Infections; COVID-19; Critical Illness; Female; Humans; Hypoxia; Male; Methylene Blue; Middle Aged; Pandemics; Pneumonia, Viral | 2020 |
Experience of N-acetylcysteine airway management in the successful treatment of one case of critical condition with COVID-19: A case report.
Topics: Acetylcysteine; Administration, Inhalation; Airway Management; Anastomosis, Surgical; Betacoronavirus; Bronchoalveolar Lavage; Coronavirus Infections; COVID-19; Humans; Intubation, Intratracheal; Length of Stay; Male; Middle Aged; Pandemics; Pneumonia, Viral; Pneumothorax; Respiration, Artificial; SARS-CoV-2 | 2020 |
High-dose N-acetylcysteine therapy for novel H1N1 influenza pneumonia.
Topics: Acetylcysteine; Antiviral Agents; Drug Therapy, Combination; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Middle Aged; Pneumonia, Viral | 2010 |